AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.09.13	AstraZeneca Begins Olaparib Phase III Trial; Reverses $285 Mln Charge (RTTNews)
03.09.13	CYTK To Take A Hit, Tune Into ESPR, Watch Out For HALO Effect (RTTNews)
02.09.13	Bristol-Myers: Onglyza Achieves Primary Safety Endpoint - Quick Facts (RTTNews)
29.08.13	M&A Activities, Pending NDA Approvals, and Clinical Trial Results - Research Report on Sanofi, GSK, AstraZeneca, Keryx, and Rigel (PR Newswire)
27.08.13	AstraZeneca's MedImmune To Buy Privately-held Amplimmune In Upto $500 Mln Deal (RTTNews)
14.08.13	Before the Bell Scans: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, and Raptor Pharma Corp. (PR Newswire)
14.08.13	Licenses, Phase III Trial Initiation and Results, and Investments - Research Report on Johnson & Johnson, Sanofi, AstraZeneca, Novartis, and GSK (PR Newswire)
01.08.13	New Antibiotic Treatment for Patients With Serious Skin Infections Becomes Available in Wales (PR Newswire)
01.08.13	AstraZeneca Q2 Profit Falls, Maintains Cautious View (RTTNews)
01.08.13	AstraZeneca Q2 Profit Decreases - Quick Facts (RTTNews)
31.07.13	AstraZeneca, FibroGen Collaborate On Anaemia Drug - Quick Facts (RTTNews)
23.07.13	Drug Approvals, Study Results, and Clinical Collaborations for Top-Line Growth - Research Report on Pfizer, Merck & Co., Cubist, AstraZeneca and Impax (PR Newswire)
22.07.13	GSK Says Chinese Executives May Have Breached Chinese Law (RTTNews)
16.07.13	Omthera Pharma Says Shareholders Support Acquisition By AstraZeneca (RTTNews)
15.07.13	AstraZeneca CFO Simon Lowth To Join BG In November As Finance Chief (RTTNews)
09.07.13	Omthera Pharma Submits NDA For Epanova To Treat Very High Triglycerides (RTTNews)
10.03.10	Astra Tech launches OsseoSpeed™ TX implant line at the Academy of Osseointegration Annual Meeting (Businesswire)
10.03.10	Astra Tech launches OsseoSpeed™ TX implant line at the Academy of Osseointegration Annual Meeting (Businesswire)
31.07.09	U.S. Food and Drug Administration Approves ONGLYZA™ (saxagliptin) for the Treatment of Type 2 Diabetes Mellitus in Adults (Businesswire)
06.06.09	Studie zu Dapagliflozin zeigte verbesserte Einstellung des Blutzuckers bei Patienten mit Typ-2-Diabetes, die mit hohen Insulindosen und üblichen oralen Antidiabetika behandelt wurden (Businesswire)
06.06.09	Zwischenanalyse der Langzeitdaten von ONGLYZA™ (Saxagliptin) als Beigabe zu Metformin zur Behandlung von unzureichend kontrolliertem Typ-2-Diabetes wird der Jahrestagung der ADA vorgelegt (Businesswire)
01.06.09	AstraZeneca and Merck & Co., Inc. Form Pioneering Collaboration to Investigate Novel Combination Anticancer Regimen (Businesswire)
28.05.08	Astra Tech World Congress Attracts Top Dental Experts (Businesswire)
14.05.08	FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder (PR Newswire)
06.05.08	MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments (PR Newswire)
30.04.08	AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication (PR Newswire)
06.11.07	AstraZeneca Announces NEXIUM(R)(esomeprazole magnesium) Savings Program for Purple Plus(TM) Members (PR Newswire)
09.10.07	Data From MedImmune Infectious Disease Clinical Programs Presented at European Society for Paediatric Research Annual Meeting (PR Newswire)
25.09.07	AstraZeneca Recognized as One of Working Mother's '100 Best Companies' for the Sixth Consecutive Year (PR Newswire)
06.06.07	AstraZeneca Extends Its Support to Greensburg, Kansas Area Residents After Devastating Tornado (PR Newswire)
03.06.07	Next Generation of Investigational Anti-Cancer Agents Unveiled at ASCO by AstraZeneca (PR Newswire)
19.02.07	Männer mit Prostatakarzinom nach mehreren Jahren Behandlung optimistischer als zum Diagnosezeitpunkt laut Ergebnissen weltweiter Umfrage(1) (PR Newswire)
06.12.06	My Medicare Matters(TM) Campaign to Award Grants for New Initiatives to Reach Low-Income Seniors (PR Newswire)
27.11.06	Medidata Rave Electronic Data Capture and Management Solution Selected by Leading Pharmaceutical Company (Businesswire)
16.11.06	New Survival Study of Vandetanib (ZACTIMA(TM), ZD6474) in Patients With Advanced Lung Cancer (PR Newswire)
13.11.06	Neue Forschungsergebnisse [1] erfordern Neueinstufung von ZOLADEX als kuratives Heilmittel (PR Newswire)
01.11.06	AstraZeneca Appoints Howard Hutchinson as Chief Medical Officer (PR Newswire)
29.09.06	AstraZeneca Joins the Congressional Black Caucus Foundation and Congressman Jesse Jackson, Jr. in the Fight Against Obesity (PR Newswire)
13.07.06	Doctors Tend to Underestimate the Emotional Impact of COPD Exacerbations - Patients Fear Being Hospitalised or Dying (PR Newswire)
08.06.06	AstraZeneca and Array BioPharma Announce Initiation of Phase II Studies for AZD6244 (ARRY-142886) (PR Newswire)
23.05.06	American Psychiatric Association and AstraZeneca Award Unique International Career Development Prizes to Top Psychiatry Researchers (PR Newswire)
23.05.06	Hundreds of Thousands of Women With Early Breast Cancer Set to Benefit From Preliminary NICE Decision (PR Newswire)
18.05.06	World's Most Comprehensive Survey of Stroke Experience Launched at European Stroke Conference (PR Newswire)
27.04.06	Abraxis BioScience Announces Co-Promotion Agreement with AstraZeneca for ABRAXANE(R) in the U.S. and the Acquisition of AstraZeneca's U.S. Branded Anesthetic and Analgesic Product Lines (Businesswire)
08.03.06	AstraZeneca Commences Patent Infringement Litigation Against IVAX (PR Newswire)
09.12.05	More Women Will Survive Breast Cancer With Arimidex (anastrozole) Than tamoxifen Data Shows (PR Newswire)
15.11.05	New Data Highlight Increased EGFR Gene Copy Number as the Most Positive Biomarker in Determining Which Patients are Most Likely to Benefit From gefitinib (Iressa(TM)) (PR Newswire)
30.10.05	Academy Prep Center's Health and Nutrition Programs Receive $50,000 Donation Through The CRESTOR(R) Charity Challenge at PGA TOUR's Chrysler Championship (PR Newswire)
02.10.05	Victory Junction Gang Camp Receives $50,000 Donation Through The CRESTOR(R) Charity Challenge at PGA TOUR's Chrysler Classic of Greensboro (PR Newswire)
18.09.05	Uniontown Hospital Receives $50,000 Donation Through The CRESTOR(R) Charity Challenge at PGA TOUR's 84 LUMBER Classic (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

18.12.24		Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer
04.12.24		Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich
03.12.24		Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende
03.12.24		Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus
03.12.24		Schwacher Wochentag in New York: NASDAQ 100 fällt am Mittag zurück
03.12.24		NASDAQ-Handel NASDAQ 100 zum Handelsstart schwächer
12.11.24		AstraZeneca-Aktie im Minus: AstraZeneca meldet starkes 3. Quartal und passt Prognose nach oben an
07.11.24		AstraZeneca-Aktie rutscht ab: Festnahme des China-Chefs von AstraZeneca

18.12.24

Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer

04.12.24

Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich

03.12.24

Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende

03.12.24

Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus

03.12.24

Schwacher Wochentag in New York: NASDAQ 100 fällt am Mittag zurück

03.12.24

NASDAQ-Handel NASDAQ 100 zum Handelsstart schwächer